@article{084f6a7e9faa4dc5b8386293198c651f,
title = "Reduced risk of mortality associated with systemic psoriasis treatment in the Psoriasis Longitudinal Assessment and Registry (PSOLAR): A nested case-control analysis",
author = "Langley, {Richard G.} and Yves Poulin and Bhaskar Srivastava and Lafferty, {Kimberly Parnell} and Steven Fakharzadeh and Wayne Langholff and Matthias Augustin",
note = "Funding Information: Editorial and writing support was provided by Cherie Koch, PhD (Synchrogenix) and Cynthia Arnold, BSc, CMPP (Janssen Scientific Affairs, LLC). Joel Gelfand, MD, MSCE (Hospital of the University of Pennsylvania, Philadelphia) and the PSOLAR Scientific Advisory Committee provided critical review of the analytical plan. Yiting Wang, PhD (Janssen Research & Development, LLC) provided critical review of this manuscript. Funding Information: Funding sources: Supported by Janssen Scientific Affairs, LLC , Horsham, Pennsylvania. Funding Information: Funding sources: Supported by Janssen Scientific Affairs, LLC, Horsham, Pennsylvania.Disclosure: Dr Langley has served and has received compensation in the form of grant funding and/or honoraria as principal investigator for and is on the scientific advisory board or has served as a speaker for AbbVie, Amgen, Boehringer Ingelheim, Celgene, Janssen, LEO Pharma, Eli Lilly, Merck, Novartis, Pfizer, Sun Pharma, and UCB. Dr Poulin has received grant funding and honoraria for services as an investigator, speaker, and member of advisory boards from AbbVie, Amgen, Bausch, Centocor/Janssen-Ortho, and UCB and has received grant funding as an investigator from Baxter, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Galderma, Genentech, GlaxoSmithKline, Eli Lilly, Incyte, LEO Pharma, MedImmune, Merck, Novartis, Pfizer, Regeneron, Serono, and Takeda. Dr Srivastava is employed by Janssen Research & Development, LLC and owns stock in Johnson & Johnson, of which Janssen is a subsidiary. Dr Lafferty is employed by Janssen Scientific Affairs, LLC, and owns stock in Johnson & Johnson, of which Janssen is a subsidiary. Dr Fakharzadeh is employed by Janssen Global Services, LLC, and owns stock in Johnson & Johnson, of which Janssen is a subsidiary. Dr Langholff is employed by Janssen Research & Development, LLC, and owns stock in Johnson & Johnson, of which Janssen is a subsidiary. Dr Augustin has served as a consultant to or paid speaker for clinical trials sponsored by companies that manufacture drugs used for the treatment of psoriasis, including AbbVie, Almirall, Amgen, Biogen, Boehringer Ingelheim, Celgene, Centocor, Eli Lilly, Fresenius, Galderma, GlaxoSmithKline, Janssen-Cilag, LEO Pharma, Medac, Merck, MSD, Novartis, Pfizer, UCB, and XenoPort. Publisher Copyright: {\textcopyright} 2020 American Academy of Dermatology, Inc.",
year = "2021",
month = jan,
doi = "10.1016/j.jaad.2020.08.032",
language = "English",
volume = "84",
pages = "60--69",
journal = "Journal of the American Academy of Dermatology",
issn = "0190-9622",
publisher = "Mosby Inc.",
number = "1",
}